2023 Annual Summit on Hematologic Cancers: Incorporation of Novel Therapies in Clinical Practice
This CME-accredited activity 2023 Annual Summit on Hematologic Cancers features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for the management of acute myeloid leukemia, acute lymphoblastic leukem
Category
  • Hematologic Malignancies
Format
  • Conference / meeting
Credits
  • ABIM MOC II
  • AMA PRA Category 1 Credit™
  • Nursing Contact Hours
Event date September 15, 2023
Multiple Myeloma & Lymphoma Summit
This CME-accredited activity “Multiple Myeloma & Lymphoma Summit” features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for management of multiple myeloma, lymphoma, and Waldenström Macroglobul
Category
  • Hematologic Malignancies
Format
  • Conference / meeting
Credits
  • ABIM MOC II
  • AMA PRA Category 1 Credit™
  • Nursing Contact Hours
Event date May 19, 2023
Alaska Multidisciplinary Oncology Conference
The Alaska Multidisciplinary Oncology Conference is a 1-day educational and scientific meeting that will focus on key clinical topics in the management of common malignancies.
Category
  • Breast Cancer
  • GI Cancers
  • Gynecologic Malignancies
  • Hematologic Malignancies
Format
  • Conference / meeting
Credits
  • ABIM MOC II
  • AMA PRA Category 1 Credit™
  • Nursing Contact Hours
Event date May 13, 2023
2023 BTF Multidisciplinary Breast Cancer Conference
The “BTF Multidisciplinary Breast Cancer Conference” is a CME-accredited activity featuring experts in breast cancer.
Category
  • Breast Cancer
Format
  • Conference / meeting
Credits
  • ABIM MOC II
  • AMA PRA Category 1 Credit™
  • Nursing Contact Hours
Event date April 1, 2023
BTF’s ASH Annual Meeting Review 2023 - Coeur d’Alene
The BTF’s ASH Annual Meeting Review 2023 - Coeur d'Alene is a CME-accredited, in-person hematology conference featuring leading experts in the field.
Category
  • Annual Meeting Reviews
  • Hematologic Malignancies
Format
  • Conference / meeting
Credits
  • ABIM MOC II
  • AMA PRA Category 1 Credit™
  • Nursing Contact Hours
Event date March 3, 2023
San Diego Multidisciplinary Thoracic Oncology Symposium: Patient-centered approach to improve outcomes
This CME-accredited activity “San Diego Multidisciplinary Thoracic Oncology Symposium: Patient-centered approach to improve outcomes” features leading experts in thoracic malignancies who will provide a comprehensive overview of current an
Category
  • Lung Cancer
Format
  • Conference / meeting
Credits
  • ABIM MOC II
  • AMA PRA Category 1 Credit™
  • Nursing Contact Hours
Event date February 3, 2023
Highlights from SABCS 2022
Management of breast cancer is rapidly evolving. A number of potentially practice-changing abstracts are expected to be presented during the 2022 San Antonio Breast Cancer Symposium (SABCS 2022) in December, 2022.
Category
  • Annual Meeting Reviews
  • Breast Cancer
  • Precision Oncology
Format
  • Conference / meeting
Credits
  • ABIM MOC II
  • AMA PRA Category 1 Credit™
  • Nursing Contact Hours
Event date January 20, 2023
2022 Cellular Therapy Conference Webcast
This accredited continuing education activity “2022 Cellular Therapy Conference Webcast”, is recorded from the live course held on 9/9-10/2022. 
Category
Format
  • Video
  • Webinar recorded
Credits
  • ABIM MOC II
  • AMA PRA Category 1 Credit™
  • Nursing Contact Hours
2022 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes- Webcast
This accredited continuing education activity “Webcast 2022 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes”, is recorded from the live webinar held on 10/07/2022- 10/08/22. 
Category
  • Breast Cancer
  • GI Cancers
  • GU Cancer
  • Hematologic Malignancies
  • Lung Cancer
  • Precision Oncology
Format
  • Video
  • Webinar recorded
Credits
  • ABIM MOC II
  • AMA PRA Category 1 Credit™
  • Nursing Contact Hours
Journal Based CME - Antibody drug conjugates (ADCs): an expanding rational treatment paradigm in breast cancer
Free journal-based oncology CME focusing on Antibody drug conjugates (ADCs), an expanding rational treatment paradigm in breast cancer
Category
  • Breast Cancer
Format
  • Journal
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Nursing Contact Hours

Pages